Oliveira LG, Lima ACG, Rodrigues FLB, Marchiori A, Rahal RMS, Abreu DCB, et al. Pathologic complete response and efficacy with neoadjuvant anthracycline followed by paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer: A real-world experience of Brazil. MAST [Internet]. 2026 Mar. 12 [cited 2026 Apr. 18];33(suppl.1). Available from: https://mastology.org/journal/article/view/1624